Top section
Top section
Innovation and ambition have been hallmarks of mergers and acquisitions activity this year, but there are some signs of weakness in private equity
A slow destruction of misallocated investment is more likely than a sudden stop
LBO financing includes $5.75bn term loan to be priced early next week
More articles
More articles
More articles
-
-
Biofarma Group launches €345m high yield bond -
The primary leveraged finance market is beginning to churn out deals again. The first European high yield deal in 10 weeks is expected to be priced this week and a handful of leveraged loans have begun the pricing process.
-
Technical difficulty and disagreements about responsibility impede progress
-
Better pricing conditions are enabling managers to refresh old deals
-
Sub-sections
shared comment list
